P C Taylor

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization
    John Bladon
    Haematology Department, Rotherham General Hospital, South Yorkshire, UK
    Transpl Int 19:319-24. 2006
  2. ncbi Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis
    Branavan Sivakumar
    Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London, United Kingdom
    J Hand Surg Am 33:49-58. 2008
  3. ncbi VEGF and imaging of vessels in rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute Division, Imperial College School of Medicine, London, UK
    Arthritis Res 4:S99-107. 2002
  4. ncbi Hypoxia and angiogenesis in rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology, Division Imperial College Faculty of Medicine, London, UK
    Curr Opin Rheumatol 17:293-8. 2005
  5. ncbi Antibody therapy for rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London W6 8LH, UK
    Curr Opin Pharmacol 3:323-8. 2003
  6. ncbi Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases
    P C Taylor
    Kennedy Institute Division, Imperial College School of Medicine, 1 Aspenlea Road, London, W6 8LH
    Mol Biotechnol 19:153-68. 2001
  7. ncbi Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy
    P C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College Faculty of Medicine, 1 Aspenlea Road, London W6 8LH, U K
    Rheumatology (Oxford) 44:721-8. 2005
  8. ncbi Anti-tumor necrosis factor therapies
    P C Taylor
    The Kennedy Institute Division, Imperial College School of Medicine, London, UK
    Curr Opin Rheumatol 13:164-9. 2001
  9. ncbi Anti-cytokines and cytokines in the treatment of rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London, W6 8LH
    Curr Pharm Des 9:1095-106. 2003
  10. ncbi Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis
    P C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, 1 Aspenlea Road, London W6 8LH, UK
    Arthritis Rheum 54:47-53. 2006

Collaborators

Detail Information

Publications28

  1. ncbi The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization
    John Bladon
    Haematology Department, Rotherham General Hospital, South Yorkshire, UK
    Transpl Int 19:319-24. 2006
    ..ECP-treated lymphocytes can reduce the ability of LPS-stimulated monocytes to produce some proinflammatory cytokines; however, this effect is not dependent on phosphatidylserine externalization...
  2. ncbi Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis
    Branavan Sivakumar
    Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London, United Kingdom
    J Hand Surg Am 33:49-58. 2008
    ..The aim of this study was to determine whether hypoxia and angiogenesis may also play a role in RA tendon disease...
  3. ncbi VEGF and imaging of vessels in rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute Division, Imperial College School of Medicine, London, UK
    Arthritis Res 4:S99-107. 2002
    ..Animal model data supports this concept. It seems likely that serological and imaging measures of vascularity in RA will become useful tools in the assessment of disease activity and response to therapy...
  4. ncbi Hypoxia and angiogenesis in rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology, Division Imperial College Faculty of Medicine, London, UK
    Curr Opin Rheumatol 17:293-8. 2005
    ..The purpose of this review is to discuss the role of hypoxia and angiogenesis in the pathogenesis of rheumatoid arthritis...
  5. ncbi Antibody therapy for rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London W6 8LH, UK
    Curr Opin Pharmacol 3:323-8. 2003
    ..Phase III studies have yet to be undertaken for these novel biological agents, and it is unclear whether any of these agents will have true disease-modifying capabilities...
  6. ncbi Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases
    P C Taylor
    Kennedy Institute Division, Imperial College School of Medicine, 1 Aspenlea Road, London, W6 8LH
    Mol Biotechnol 19:153-68. 2001
    ....
  7. ncbi Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy
    P C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College Faculty of Medicine, 1 Aspenlea Road, London W6 8LH, U K
    Rheumatology (Oxford) 44:721-8. 2005
    ..Power Doppler imaging may also have the potential to predict those patients most at risk of accelerated joint destruction. However, much work has yet to be done to standardize the use of these imaging technologies...
  8. ncbi Anti-tumor necrosis factor therapies
    P C Taylor
    The Kennedy Institute Division, Imperial College School of Medicine, London, UK
    Curr Opin Rheumatol 13:164-9. 2001
    ..In conclusion, for patients with established and early RA, anti-TNF therapies set a new standard for symptom control and joint protection...
  9. ncbi Anti-cytokines and cytokines in the treatment of rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London, W6 8LH
    Curr Pharm Des 9:1095-106. 2003
    ..In this review I will also discuss the rationale and preliminary data for other potential therapeutic strategies designed to augment the activity of anti-inflammatory cytokines such as IL-4, IL-10, and IL-11 in rheumatoid disease...
  10. ncbi Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis
    P C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, 1 Aspenlea Road, London W6 8LH, UK
    Arthritis Rheum 54:47-53. 2006
    ..To compare the impact of immediate and delayed introduction of anti-tumor necrosis factor therapy on inflammation and structural damage in methotrexate (MTX)-treated patients with early rheumatoid arthritis (RA)...
  11. ncbi Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
    S Ballara
    Imperial College School of Medicine, London, UK
    Arthritis Rheum 44:2055-64. 2001
    ....
  12. ncbi Anti-cytokine therapy for rheumatoid arthritis
    R N Maini
    Kennedy Institute of Rheumatology, London, UK
    Annu Rev Med 51:207-29. 2000
    ..One anti-TNF reagent has already been approved in the United States for the treatment of RA, and other cytokine antagonists or agonists are under development...
  13. ncbi Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
    R N Maini
    Kennedy Institute of Rheumatology Division, Imperial College, London, UK
    Arthritis Rheum 54:2817-29. 2006
    ....
  14. ncbi Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis
    P C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, London, UK
    Arthritis Rheum 50:1107-16. 2004
    ....
  15. ncbi Reproducibility of sodium MRI measures of articular cartilage of the knee in osteoarthritis
    R D Newbould
    GSK Clinical Imaging Centre, Hammersmith Hospital, Imperial College London, London, UK
    Osteoarthritis Cartilage 20:29-35. 2012
    ..To determine the stability and reproducibility of the sodium magnetic resonance imaging (MRI) signal measured in the articular cartilage of the knee in both healthy volunteers and osteoarthritis (OA) patients...
  16. ncbi Immunotherapy for rheumatoid arthritis
    P C Taylor
    The Kennedy Institute Division, Imperial College School of Medicine, 1 Aspenlea Road, W6 8LH, London, UK
    Curr Opin Immunol 13:611-6. 2001
    ..Thus, for patients with RA, anti-TNF therapies set a new standard for symptom control and joint protection...
  17. ncbi Transfer of type II collagen-induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac-1
    P C Taylor
    Kennedy Institute of Rheumatology, London, UK
    Immunology 88:315-21. 1996
    ..Our findings support the hypothesis that cells expressing Mac-1 play an important role in the induction and maintenance of joint damage in collagen-induced arthritis...
  18. ncbi Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London W68LH, UK
    Curr Opin Biotechnol 15:557-63. 2004
    ..Better understanding of these pathogenic pathways will inform the development of new therapeutic approaches leading to more complete and sustained disease remissions...
  19. ncbi Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
    Peter C Taylor
    Kennedy Institute of Rheumatology Division, Imperial College Faculty of Medicine, London, UK
    Nat Clin Pract Rheumatol 2:128-9. 2006
  20. ncbi Monoclonal antibodies in immune and inflammatory diseases
    Evangelos Andreakos
    Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, 1 Aspenlea Road, Hammersmith, W6 8LH, London, UK
    Curr Opin Biotechnol 13:615-20. 2002
    ..In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of diseases including rheumatoid arthritis, Crohn's disease, spondyloarthropathies, psoriasis and allograft rejection...
  21. ncbi Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis
    Andrew Kinloch
    Kennedy Institute of Rheumatology, Imperial College London, Charing Cross Hospital Campus, 1 Aspenlea Road, London W6 8LH, UK
    Arthritis Res Ther 7:R1421-9. 2005
    ..The presence of antibody together with expression of antigen within the joint implicates citrullinated alpha-enolase as a candidate autoantigen that could drive the chronic inflammatory response in RA...
  22. ncbi Anti-TNF therapy: where have we got to in 2005?
    Marc Feldmann
    Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College, 1 Aspenlea Road, London W6 8LH, UK
    J Autoimmun 25:26-8. 2005
    ..There are still many limitations, but the prospects for the future are intriguing...
  23. ncbi Anti-TNFalpha therapy for rheumatoid arthritis: an update
    Peter C Taylor
    Kennedy Institute Division, Faculty of Medicine, Imperial College School of Science, Technology and Medicine, 1 Aspenlea Road, London W6 8LH
    Intern Med 42:15-20. 2003
    ..In conclusion, for patients with established and early RA, anti-TNF therapies set a new standard for symptom control and joint protection...
  24. ncbi New approaches to therapeutic immunomodulation for immune-mediated inflammatory disorders
    Peter C Taylor
    Curr Opin Pharmacol 4:368-71. 2004
  25. ncbi Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes
    John Bladon
    Department of Haematology, Rotherham General Hospital, South Yorkshire, UK
    Photodermatol Photoimmunol Photomed 21:293-302. 2005
    ..ECP-treated cells are re-infused immediately after completion of treatment. This study attempted to determine the influence that ECP-treated cells would have on untreated cells following re-infusion...
  26. ncbi Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response
    Betsy J Evans
    BHF Cardiovascular Medicine Unit, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
    Blood 107:3593-9. 2006
    ..We hypothesize that LFA-1 shedding may play a role in leukocyte detachment after transendothelial migration and in regulating integrin-dependent outside-in signaling...
  27. ncbi Immune functions are maintained in healthy men with low zinc intake
    Kathryn Pinna
    Department of Nutritional Sciences, University of California, Berkeley 94720, USA
    J Nutr 132:2033-6. 2002
    ..The results suggest that changes in lymphocyte proliferation and IL-2R expression may be early markers of mild zinc deficiency...
  28. ncbi The value of sensitive imaging modalities in rheumatoid arthritis
    Peter C Taylor
    The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, UK
    Arthritis Res Ther 5:210-3. 2003
    ..However, further research using these sensitive imaging technologies is required to delineate pathophysiological correlates of imaging abnormalities and to standardise methods for assessment...